At 25 mg/kg, RMC-6236 was able to maintain more than 80% inhibition of pERK levels in tumors up to 24 hours post-dose comparable with the inhibition pattern of DUSP6 levels in tumor lysates. This evidence concerns the gene EIF2AK3 and neoplasm.